Share on StockTwits

Oncolytics Biotech (NASDAQ:ONCY) announced its earnings results on Thursday. The company reported ($0.05) earnings per share for the quarter, beating the analysts’ consensus estimate of ($0.07) by $0.02, Analyst Ratings Network reports.

Shares of Oncolytics Biotech (NASDAQ:ONCY) traded up 0.75% during mid-day trading on Thursday, hitting $1.3299. 15,007 shares of the company’s stock traded hands. Oncolytics Biotech has a 52 week low of $1.20 and a 52 week high of $3.50. The stock has a 50-day moving average of $1.40 and a 200-day moving average of $1.52. The company’s market cap is $115.1 million.

ONCY has been the subject of a number of recent research reports. Analysts at Zacks downgraded shares of Oncolytics Biotech from an “outperform” rating to a “neutral” rating in a research note on Monday. They now have a $1.60 price target on the stock.

Oncolytics Biotech Inc (NASDAQ:ONCY) is a development-stage company.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.